These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36587552)

  • 1. Synthesis and biophysical properties of tetravalent PEG-conjugated antisense oligonucleotide.
    Rahman Chowdhury T; Taufiq T; Ishida K; Ariful Islam M; Kasahara Y; Osawa T; Obika S
    Bioorg Med Chem; 2023 Jan; 78():117149. PubMed ID: 36587552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.
    Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S
    J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides.
    Wang D; Wang Q; Wang Y; Chen P; Lu X; Jia F; Sun Y; Sun T; Zhang L; Che F; He J; Lian L; Morano G; Shen M; Ren M; Dong SS; Zhao JJ; Zhang K
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2113180119. PubMed ID: 35858356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-modification on the endo-position of an antisense oligonucleotide increases tumor accumulation via the EPR effect.
    Hagiwara K; Kurihara K; Honma M; Yamamoto J; Shinohara F
    J Biomater Sci Polym Ed; 2018 Mar; 29(4):448-459. PubMed ID: 29318941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents.
    Shokrzadeh N; Winkler AM; Dirin M; Winkler J
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5758-5761. PubMed ID: 25453815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides.
    Kaniowski D; Kulik K; Suwara J; Ebenryter-Olbińska K; Nawrot B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of antisense oligonucleotide functionalized core-shell nanoparticles loaded with α-tocopherol succinate.
    Kilicay E; Karahaliloglu Z; Alpaslan P; Hazer B; Denkbas EB
    J Biomater Sci Polym Ed; 2017 Oct; 28(15):1762-1785. PubMed ID: 28696185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Assembled DNA-PEG Bottlebrushes Enhance Antisense Activity and Pharmacokinetics of Oligonucleotides.
    Wang Y; Wang D; Jia F; Miller A; Tan X; Chen P; Zhang L; Lu H; Fang Y; Kang X; Cai J; Ren M; Zhang K
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45830-45837. PubMed ID: 32936615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of multivalent fatty acid-conjugated antisense oligonucleotides: Cell internalization, physical properties, and in vitro and in vivo activities.
    Tanaka Y; Tanioku Y; Nakayama T; Aso K; Yamaguchi T; Kamada H; Obika S
    Bioorg Med Chem; 2023 Mar; 81():117192. PubMed ID: 36780806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides.
    Bonora GM; Ivanova E; Zarytova V; Burcovich B; Veronese FM
    Bioconjug Chem; 1997; 8(6):793-7. PubMed ID: 9404651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
    Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
    Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Assessment of the Clinical Performance of GalNAc
    Crooke ST; Baker BF; Xia S; Yu RZ; Viney NJ; Wang Y; Tsimikas S; Geary RS
    Nucleic Acid Ther; 2019 Feb; 29(1):16-32. PubMed ID: 30570431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gapmer Antisense Oligonucleotides Targeting 5S Ribosomal RNA Can Reduce Mature 5S Ribosomal RNA by Two Mechanisms.
    Pollak AJ; Hickman JH; Liang XH; Crooke ST
    Nucleic Acid Ther; 2020 Oct; 30(5):312-324. PubMed ID: 32589504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling for reduction of hepatic apolipoprotein B mRNA and plasma total cholesterol after administration of antisense oligonucleotide in mice.
    Shimizu R; Kitade M; Kobayashi T; Hori S; Watanabe A
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):67-77. PubMed ID: 25376372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect.
    Gaziova Z; Baumann V; Winkler AM; Winkler J
    Bioorg Med Chem; 2014 Apr; 22(7):2320-6. PubMed ID: 24613624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complex.
    Wong FM; MacAdam SA; Kim A; Oja C; Ramsay EC; Bally MB
    J Drug Target; 2002 Dec; 10(8):615-23. PubMed ID: 12683666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle.
    Prakash TP; Mullick AE; Lee RG; Yu J; Yeh ST; Low A; Chappell AE; Østergaard ME; Murray S; Gaus HJ; Swayze EE; Seth PP
    Nucleic Acids Res; 2019 Jul; 47(12):6029-6044. PubMed ID: 31127296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties.
    Sela T; Mansø M; Siegel M; Marban-Doran C; Ducret A; Niewöhner J; Ravn J; Martin RE; Sommer A; Lohmann S; Krippendorff BF; Ladefoged M; Indlekofer A; Quaiser T; Bueddefeld F; Koller E; Mohamed MY; Oelschlaegel T; Gothelf KV; Hofer K; Schumacher FF
    Bioconjug Chem; 2023 Nov; 34(11):2096-2111. PubMed ID: 37916986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands.
    Dirin M; Urban E; Noe CR; Winkler J
    Eur J Med Chem; 2016 Oct; 121():132-142. PubMed ID: 27236069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.